Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Antimicrobial wash use would benefit special groups, such as the military -- Leyden.

This article was originally published in The Tan Sheet

Executive Summary

ANTIMICROBIAL HAND/BODY WASHES WOULD BENEFIT SPECIAL POPULATIONS, such as the military and individuals infected with HIV, dermatologist James Leyden, MD, University of Pennsylvania, said at FDA's Nonprescription Drugs Advisory Committee meeting in Bethesda, Md. July 29. Leyden identified the military, individuals with high levels of Staphylococcus aureus, such as those with atopic dermatitis or HIV, and people who have compromised stratum corneum as those who would benefit from using antimicrobial products. Another guest speaker, Elaine Larson, Georgetown University School of Nursing, said day care environments would be another setting where antiseptic agents would be useful because of the frequency of viral outbreaks.

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

OM010563

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel